Patient advocate by choice: Solve M.E.’s Oved Amitay

This article by Charlotte Kilpatrick  originally appeared on Although the World Vaccine Congress West Coast is a few months away, we and our speakers are already gearing up and preparing a […]

Exciting Changes at Solve!

Dear Friend, I joined Solve as CEO in 2020, when we embarked on a strategy that connected ME/CFS with Long Covid, which was just emerging at that time as a […]

Solve M.E. CEO Oved Amitay On Potential EBV Vaccine Candidate

Originally published by Solve M.E. CEO Oved Amitay in a LinkedIn post. Very encouraging to learn today that top experts from OPKO Health, Inc. and ModeX Therapeutics Inc team up with Merck to develop Epstein-BarrVirus Vaccine Candidate. […]